Cargando…
Effects of Body Mass Index, Glycemic Control, and Hypoglycemic Drugs on Serum Uric Acid Levels in Type 2 Diabetic Patients
Background Plasma uric acid has been shown to be associated with an increased risk of hypertension, cardiovascular disease, chronic kidney disease, insulin resistance, and metabolic syndrome. Conflicting data regarding plasma uric acid levels in type 2 diabetes mellitus and their role in the develop...
Autores principales: | Hussain, Azhar, Latiwesh, Omar B, Ali, Farwa, Younis, M.Y. G, Alammari, Jamal A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193568/ https://www.ncbi.nlm.nih.gov/pubmed/30349765 http://dx.doi.org/10.7759/cureus.3158 |
Ejemplares similares
-
Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients
por: Peela, Jagannadha R, et al.
Publicado: (2018) -
A Comprehensive Review of the Manifestations and Pathogenesis of Zika Virus in Neonates and Adults
por: Hussain, Azhar, et al.
Publicado: (2018) -
Warfarin Dosing Requirement According to Body Mass Index
por: Alshammari, Abdullah, et al.
Publicado: (2020) -
Elevated Serum Uric Acid and Cardiovascular Disease: A Review and Potential Therapeutic Interventions
por: Freilich, Michael, et al.
Publicado: (2022) -
Serum Uric Acid and Lipid Levels in Patients With Acute Ischemic Stroke: A Cross-Sectional Study
por: Lokkanahalli, SelvaKumar S, et al.
Publicado: (2022)